Evidence map›Paper›PMID 26883621›Full record

ArticleBMC public health2016

The first mile: community experience of outbreak control during an Ebola outbreak in Luwero District, Uganda.

Daniel H de Vries, Jude T Rwemisisi, Laban K Musinguzi, Turinawe E Benoni, Denis Muhangi, Marije de Groot, David Kaawa-Mafigiri, Robert Pool

Registry-linked trialAbstract read
In one paragraph

Article in BMC public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02818582 (PREVAIL IV), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02818582 phase2completednot on this map

PREVAIL IV: Double-Blind, Randomized, Two-Phase, Placebo-Controlled, Phase II Trial of GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2016 to 2020Enrolled38ConditionsEbolaArmsGS-5734, Placebo Comparator
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel H de VriesDepartment of Anthropology, University of Amsterdam, Amsterdam, The Netherlands. d.h.devries@uva.nl.
Jude T RwemisisiDepartment of Anthropology, University of Amsterdam, Amsterdam, The Netherlands.
Laban K MusinguziDepartment of Anthropology, University of Amsterdam, Amsterdam, The Netherlands.
Turinawe E BenoniDepartment of Anthropology, University of Amsterdam, Amsterdam, The Netherlands.
Denis MuhangiDepartment of Social Work and Social Administration, Makerere University, Kampala, Uganda.
Marije de GrootDepartment of Anthropology, University of Amsterdam, Amsterdam, The Netherlands.
David Kaawa-MafigiriCenter for Social Science Research on AIDS (CeSSRA), School of Social Sciences, Makerere University, Kampala, Uganda.
Robert PoolDepartment of Anthropology, University of Amsterdam, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA major challenge to outbreak control lies in early detection of viral haemorrhagic fevers (VHFs) in local community contexts during the critical initial stages of an epidemic, when risk of spreading is its highest ("the first mile"). In this paper we document how a major Ebola outbreak control effort in central Uganda in 2012 was experienced from the perspective of the community. We ask to what extent the community became a resource for early detection, and identify problems encountered with community health worker and social mobilization strategies.

methodsAnalysis is based on first-hand ethnographic data from the center of a small Ebola outbreak in Luwero Country, Uganda, in 2012. Three of this paper's authors were engaged in an 18 month period of fieldwork on community health resources when the outbreak occurred. In total, 13 respondents from the outbreak site were interviewed, along with 21 key informants and 61 focus group respondents from nearby Kaguugo Parish. All informants were chosen through non-probability sampling sampling.

resultsOur data illustrate the lack of credibility, from an emic perspective, of biomedical explanations which ignore local understandings. These explanations were undermined by an insensitivity to local culture, a mismatch between information circulated and the local interpretative framework, and the inability of the emergency response team to take the time needed to listen and empathize with community needs. Stigmatization of the local community--in particular its belief in amayembe spirits--fuelled historical distrust of the external health system and engendered community-level resistance to early detection.

conclusionsGiven the available anthropological knowledge of a previous outbreak in Northern Uganda, it is surprising that so little serious effort was made this time round to take local sensibilities and culture into account. The "first mile" problem is not only a question of using local resources for early detection, but also of making use of the contextual cultural knowledge that has already been collected and is readily available. Despite remarkable technological innovations, outbreak control remains contingent upon human interaction and openness to cultural difference.

Indexed as

Anthropology, CulturalCommunicable Disease ControlCommunicationCommunity Health WorkersCultureDisease OutbreaksHemorrhagic Fever, EbolaHumansPublic Health SurveillanceResidence CharacteristicsSocial StigmaUganda

Identifiers

PMID26883621
PMCPMC4754807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.